Stryker PE Ratio 2006-2019 | SYK
Current and historical p/e ratio for Stryker (SYK) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stryker PE ratio as of October 18, 2019 is 27.89.
| Stryker PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-10-18 | 215.32 | 23.05 | |
| 2019-06-30 | 205.58 | $9.34 | 22.01 |
| 2019-03-31 | 197.52 | $9.27 | 21.31 |
| 2018-12-31 | 156.75 | $9.34 | 16.78 |
| 2018-09-30 | 177.09 | $3.24 | 54.66 |
| 2018-06-30 | 167.84 | $2.83 | 59.31 |
| 2018-03-31 | 159.51 | $2.67 | 59.74 |
| 2017-12-31 | 153.03 | $2.68 | 57.10 |
| 2017-09-30 | 139.93 | $4.68 | 29.90 |
| 2017-06-30 | 136.33 | $4.48 | 30.43 |
| 2017-03-31 | 128.93 | $4.45 | 28.97 |
| 2016-12-31 | 116.96 | $4.35 | 26.89 |
| 2016-09-30 | 113.24 | $4.39 | 25.79 |
| 2016-06-30 | 116.19 | $4.24 | 27.40 |
| 2016-03-31 | 103.69 | $4.27 | 24.28 |
| 2015-12-31 | 89.50 | $3.78 | 23.68 |
| 2015-09-30 | 90.26 | $3.07 | 29.40 |
| 2015-06-30 | 91.33 | $2.44 | 37.43 |
| 2015-03-31 | 87.84 | $1.97 | 44.59 |
| 2014-12-31 | 89.49 | $1.57 | 57.00 |
| 2014-09-30 | 76.33 | $1.91 | 39.96 |
| 2014-06-30 | 79.41 | $2.02 | 39.31 |
| 2014-03-31 | 76.45 | $2.02 | 37.85 |
| 2013-12-31 | 70.24 | $2.63 | 26.71 |
| 2013-09-30 | 62.93 | $2.33 | 27.01 |
| 2013-06-30 | 59.99 | $2.98 | 20.13 |
| 2013-03-31 | 60.26 | $3.27 | 18.43 |
| 2012-12-31 | 50.43 | $3.39 | 14.88 |
| 2012-09-30 | 50.96 | $3.73 | 13.66 |
| 2012-06-30 | 50.25 | $3.65 | 13.77 |
| 2012-03-31 | 50.40 | $3.59 | 14.04 |
| 2011-12-31 | 44.99 | $3.46 | 13.00 |
| 2011-09-30 | 42.47 | $3.15 | 13.48 |
| 2011-06-30 | 52.69 | $3.16 | 16.67 |
| 2011-03-31 | 54.42 | $3.17 | 17.17 |
| 2010-12-31 | 47.92 | $3.19 | 15.02 |
| 2010-09-30 | 44.52 | $3.21 | 13.87 |
| 2010-06-30 | 44.39 | $2.93 | 15.15 |
| 2010-03-31 | 50.59 | $2.86 | 17.69 |
| 2009-12-31 | 44.42 | $2.77 | 16.04 |
| 2009-09-30 | 39.87 | $2.70 | 14.77 |
| 2009-06-30 | 34.87 | $2.79 | 12.50 |
| 2009-03-31 | 29.87 | $2.79 | 10.71 |
| 2008-12-31 | 35.06 | $2.78 | 12.61 |
| 2008-09-30 | 54.12 | $2.75 | 19.68 |
| 2008-06-30 | 54.62 | $2.64 | 20.69 |
| 2008-03-31 | 56.51 | $2.56 | 22.07 |
| 2007-12-31 | 64.91 | $2.44 | 26.60 |
| 2007-09-30 | 59.47 | $2.33 | 25.52 |
| 2007-06-30 | 54.57 | $2.24 | 24.36 |
| 2007-03-31 | 57.36 | $2.11 | 27.18 |
| 2006-12-31 | 47.66 | $1.89 | 25.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $80.642B | $13.601B |
| Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $145.598B | 26.57 |
| Medtronic (MDT) | Ireland | $145.585B | 20.43 |
| Boston Scientific (BSX) | United States | $53.170B | 25.79 |
| Baxter (BAX) | United States | $44.852B | 27.20 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $32.725B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.438B | 18.20 |
| Coloplast (CLPBY) | Denmark | $25.747B | 41.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.481B | 0.00 |
| Terumo (TRUMY) | Japan | $24.495B | 30.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.928B | 0.00 |
| ResMed (RMD) | United States | $18.924B | 36.06 |
| Sunny Optical Technology (SNPTF) | China | $16.014B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.234B | 54.86 |
| Insulet (PODD) | United States | $9.431B | 558.86 |
| Perrigo (PRGO) | Ireland | $7.400B | 13.63 |
| Canopy Growth (CGC) | Canada | $7.222B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.830B | 20.36 |
| Haemonetics (HAE) | United States | $6.455B | 48.71 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.344B | 27.61 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $4.002B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.680B | 0.00 |
| Neogen (NEOG) | United States | $3.490B | 58.40 |
| NuVasive (NUVA) | United States | $3.398B | 27.09 |
| ICU Medical (ICUI) | United States | $3.237B | 21.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.634B | 0.00 |
| Quidel (QDEL) | United States | $2.510B | 24.93 |
| Agios Pharmaceuticals (AGIO) | United States | $1.982B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.877B | 40.51 |
| Cardiovascular Systems (CSII) | United States | $1.670B | 0.00 |
| Aphria (APHA) | $1.242B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.124B | 25.90 |
| AtriCure (ATRC) | United States | $1.059B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.867B | 14.10 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.854B | 21.78 |
| NanoString Technologies (NSTG) | United States | $0.787B | 0.00 |
| Omeros (OMER) | United States | $0.759B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.734B | 19.29 |
| PetIQ (PETQ) | United States | $0.725B | 17.13 |
| LeMaitre Vascular (LMAT) | United States | $0.689B | 40.82 |
| Cerus (CERS) | United States | $0.624B | 0.00 |
| Surmodics (SRDX) | United States | $0.621B | 118.00 |
| MacroGenics (MGNX) | United States | $0.560B | 0.00 |
| Quanterix (QTRX) | United States | $0.548B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.530B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.523B | 24.23 |
| Owens & Minor (OMI) | United States | $0.459B | 13.76 |
| Meridian Bioscience (VIVO) | United States | $0.427B | 13.32 |
| Utah Medical Products (UTMD) | United States | $0.354B | 25.91 |
| Zynex (ZYXI) | United States | $0.346B | 36.76 |
| BioLife Solutions (BLFS) | United States | $0.339B | 104.19 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.327B | 0.00 |
| Bovie Medical (APYX) | United States | $0.234B | 0.00 |
| United Health Products (UEEC) | United States | $0.208B | 0.00 |
| Vapotherm (VAPO) | United States | $0.177B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.153B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.147B | 0.00 |
| Female Health (VERU) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.133B | 9.32 |
| InfuSystems Holdings (INFU) | United States | $0.127B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.104B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Nephros (NEPH) | United States | $0.087B | 0.00 |
| United-Guardian (UG) | United States | $0.084B | 19.82 |
| MTech Acquisition (KERN) | United States | $0.063B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.058B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Surface Oncology (SURF) | United States | $0.039B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.018B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
